J. Mittermüller

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

H-J Kolb, J. Mittermüller, Ch. Clemm et al. · Blood · 1990 · 1.5K citations · Full text

Medicine, Hematology, Oncology +16

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

Ernst Holler, HJ Kolb, J. Mittermüller et al. · Blood · 1995 · 195 citations · Full text

Life Sciences, Immunology, Immunoregulation +15

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · Journal of Clinical Oncology · 2011 · 117 citations

Medicine, Oncology, Pharmacology +14

Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.

Ernst Holler, HJ Kolb, R. Hintermeíer-Knabe et al. · PubMed · 1993 · 105 citations

Life Sciences, Hematology, Immunology +16

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

HJ Kolb, J. Mittermüller, Ch. Clemm et al. · Blood · 1990 · 93 citations

Medicine, Hematology, Oncology +16